Facharzt FMH Allgemeine Innere Medizin
Facharzt FMH Allgemeine Innere Medizin (Switzerland)
Endocrinology MetabolismEnglish
Exam overviewPractice session
A 58-year-old male with established type 2 diabetes mellitus (HbA1c 8.2%), obesity (BMI 34 kg/m²), and a history of prior myocardial infarction 3 years ago is seen in clinic. His current medication is metformin 1000 mg twice daily. His eGFR is 75 mL/min/1.73 m². According to ADA/EASD and Swiss consensus guidelines, which class of glucose-lowering medications with proven major adverse cardiovascular event (MACE) reduction should be added?
Loading your practice session…